Monday, June 15, 2026

Policy

Policy•Fierce Biotech•Jun 13, 2026

Lilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’

background ▾

• •Lilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’

→ Read original article

Policy•Fierce Biotech•Jun 12, 2026

‘I wouldn’t call it a blip’: Biotech IPOs here to stay after another record-breaking listing

background ▾

• •‘I wouldn’t call it a blip’: Biotech IPOs here to stay after another record-breaking listing

→ Read original article

Policy•Fierce Biotech•Jun 11, 2026

‘Not simply saving cost’: Inside Astellas CEO’s 5-year strategy to counter Xtandi’s patent cliff

background ▾

• •‘Not simply saving cost’: Inside Astellas CEO’s 5-year strategy to counter Xtandi’s patent cliff

→ Read original article

Policy•STAT News•Jun 15, 2026

Opinion: I’m a pediatrician. I want to prescribe the right AI to my patients

background ▾

• •Opinion: I’m a pediatrician. I want to prescribe the right AI to my patients

→ Read original article

Policy•Fierce Pharma•Jun 15, 2026

In latest twist in Zepzelca saga, Jazz and PharmaMar lung cancer drug fails phase 3 test

background ▾

• •In latest twist in Zepzelca saga, Jazz and PharmaMar lung cancer drug fails phase 3 test

→ Read original article

Market Access

No articles for this category on this date.

Clinical Trials

No articles for this category on this date.